Physician profile
Scott Eisenberg
NPI 1891778353
$131,738.74
in general payments reported to CMS, 2019-2025
49 companies · $2,614 in 2025
The $2,614 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $37K · 2021: $27K · 2022: $21K · 2023: $3,961 · 2024: $4,120 · 2025: $2,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,748 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,580 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,747.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,580.00 |
| Education | $367.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $68,392.43 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $45,594.62 | 2019-2025 | Farxiga, Lynparza |
| Novartis Pharmaceuticals Corporation | $4,443.44 | 2019-2025 | |
| Esperion Therapeutics, INC. | $2,218.08 | 2020-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $1,821.53 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Boston Scientific Corporation | $1,471.66 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Bodyguardian |
| Amgen INC. | $920.97 | 2020-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $544.02 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $493.99 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Irhythm Technologies, INC. | $478.00 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $452.52 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.46 | 2019-2025 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $297.19 | 2019-2023 | Livalo |
| Pfizer INC. | $284.85 | 2019-2025 | |
| United Therapeutics Corporation | $278.81 | 2019-2025 | Tyvaso, Tyvaso |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $255.29 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $229.32 | 2019-2025 | |
| Medtronic, INC. | $215.85 | 2021-2025 | Micra, Onyx Frontier |
| Arbor Pharmaceuticals, INC. | $215.21 | 2019-2021 | |
| Abbott Laboratories | $200.20 | 2021-2024 | Accent, Aveir, Jot Dx |
| Amarin Pharma, INC. | $194.60 | 2019-2023 | |
| Acist Medical Systems, INC. | $190.26 | 2023-2024 | |
| Abiomed | $173.69 | 2019-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $169.51 | 2019-2025 | Evkeeza |
| Bard Peripheral Vascular, INC. | $161.19 | 2025 | Rotarexs 6 F X 135 Cm |
| Cvrx, INC. | $153.89 | 2021-2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $141.76 | 2021-2023 | Arcalyst |
| Atricure, INC. | $139.45 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Novo Nordisk INC | $134.75 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $102.36 | 2024-2025 | Assure Wcd |
| W. L. Gore & Associates, INC. | $102.16 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $102.02 | 2024-2025 | Onpattro, Amvuttra |
| Lundbeck LLC | $96.44 | 2019-2020 | |
| Genzyme Corporation | $79.17 | 2021-2024 | |
| Silk Road Medical, INC. | $78.40 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Glaxosmithkline, LLC. | $66.65 | 2025 | Shingrix |
| Philips North America LLC | $54.65 | 2024-2025 | (5044) Mcot, Lm Accessories |
| Tactile Systems Technology INC | $52.91 | 2025 | Flexitouch Plus, Nimbl |
| Chiesi USA, INC. | $46.46 | 2025 | Juxtapid |
| Akcea Therapeutics, INC. | $40.27 | 2019-2021 | |
| Aegerion Pharmaceuticals, INC. | $37.92 | 2019 | |
| Agepha Pharma Fz LLC | $35.07 | 2024-2025 | Lodoco |
| Kiniksa Pharmaceuticals International, Plc | $35.00 | 2024 | Arcalyst |
| Corcept Therapeutics | $32.75 | 2024-2025 | Korlym |
| Bridgebio Pharma, INC. | $32.09 | 2025 | Attruby |
| Imperative Care, INC | $29.60 | 2025 | Prodigy Catheter |
| Daiichi Sankyo INC. | $17.68 | 2023 | Injectafer |
| Scpharmaceuticals INC. | $15.60 | 2025 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.